Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2023-06-06 | New | $464,767 | $464,767 | Debt Only | 06b | SEC link |
| 2020-07-01 | New | $11,239,731 | $11,239,731 | Equity and Debt | 06b | SEC link |
| 2019-03-22 | New | $6,689,846 | $6,689,846 | Equity Only | 06b | SEC link |
| 2016-11-02 | New | Yet to Sell | $0 | Equity Only | 06c | SEC link |
| 2015-12-28 | New | $2,030,403 | $2,030,403 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Christopher Benoit | Director |
| Richard C. Birkmeyer, Ph D | Director, Executive |
| Brian Chirico | Executive |
| John Davidson | Director, Executive |
| Vance V. Kershner | Director |
| Alan Levin | Director |
| Christopher Mc Leod | Director |
| John Nobile | Director |
| Dan Wagner | Director |
| Daniel Wagner | Director |